HomeSZLS • TSE
add
StageZero Life Sciences Ltd
Previous close
$0.040
Year range
$0.040 - $0.060
Market cap
4.92M CAD
P/E ratio
-
Dividend yield
-
Primary exchange
TSE
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | 390.08K | -50.83% |
Operating expense | 703.10K | -22.60% |
Net income | -649.46K | -61.74% |
Net profit margin | -166.49 | -228.90% |
Earnings per share | — | — |
EBITDA | -651.47K | 14.41% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 20.72K | -67.73% |
Total assets | 583.74K | -25.59% |
Total liabilities | 11.32M | 23.10% |
Total equity | -10.74M | — |
Shares outstanding | 123.53M | — |
Price to book | -0.44 | — |
Return on assets | -360.92% | — |
Return on capital | 20.34% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -649.46K | -61.74% |
Cash from operations | -62.92K | -991.86% |
Cash from investing | — | — |
Cash from financing | 78.11K | 274.50% |
Net change in cash | 15.18K | -45.59% |
Free cash flow | 220.88K | 447.29% |
About
Founded
1997
Headquarters
Website
Employees
40
